Organoplate graft microfluidic 3D cell culture plates, catalog number: 6401-400-B
Ended Purchase Order Awarded
- Contract number
- 75N95021P00280
- Awardee
-
Mimetas Operations US, CO. UEI M9RJXA9M7L68
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $29,125
Award facts
- Opportunity
-
- 75N95021P00280 Solicitation number
- Contract value 100% obligated
- $29,125.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Gaithersburg, MD 20878, USA
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract 75N95021P00280?
75N95021P00280 was awarded to Mimetas Operations US, CO. by National Institute on Drug Abuse (National Institutes of Health) on June 14, 2021.
How much is contract 75N95021P00280 worth?
The government has obligated $29,125 on 75N95021P00280.
Which agency awarded contract 75N95021P00280?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95021P00280, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95021P00280 competed?
The extent of competition for 75N95021P00280 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award